Not all elevations in serum creatinine portend bad outcomes‼️
#Nephpearls #NephSAP
Permissive AKI in the treatment of heart failure ca. 2019 from @Kidney_Int @scoca1 @KidneydrChirag
#Nephpearls #Cardiorenal
👉🏼 kidney-international.org/article/S0085-…
We do not yet know whether stopping RAAS blockade in stage 4 or 5 CKD improves outcomes ... await @STOPACEi_trial findings
📌 One of the controversies raised during #KDIGOBPinCKD 🇬🇧 meeting #Nephpearls
👉🏼 kdigo.org/wp-content/upl…
Currently, there is uncertainty as to whether the potential improvements in mortality & morbidity brought about by delaying ESKD and dialysis conferred by cessation of ACEi/ ARB off-set any increase in CVD by their omission #Nephpearls
👉🏼 karger.com/Article/Pdf/44…
Proposed approach to managing serum creatinine elevations during hypertension management ca. 2020 from @AmJNephrol @KidneydrChirag #Nephpearls
👉🏼 karger.com/Article/Pdf/50…
Continuing ACE-I or ARB therapy in patients with declining kidney function may be associated with CV benefit without excessive harm of ESKD (ca. 2020) from @JAMAInternalMed @JAMA_current @meg21212 @alexchangmd @LesleyInker @JoeCoresh #Nephpearls
👉🏼 jamanetwork.com/journals/jamai…
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.